Cost-effectiveness analysis of interventions for migraine in four low- and middle-income countries
Open accessThe DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Evidence of the cost and effects of interventions for reducing the global burden of migraine remains scarce. Our objective was to estimate the population-level cost-effectiveness of evidence-based migraine interventions and their contributions towards reducing current burden in low- and middle-income countries. METHODS: Using a standard WHO approach to cost-effectiveness analysis (CHOICE), we modelled core set intervention strategies for migraine, taking account of coverage and efficacy as well as non-adherence. The setting was primary health care including pharmacies. We modelled 26 intervention strategies implemented during 10 years. These included first-line acute and prophylactic drugs, and the expected consequences of adding consumer-education and provider-training. Total population-level costs and effectiveness (healthy life years [HLY] gained) were combined to form average and incremental cost-effectiveness ratios. We executed runs of the model for the general populations of China, India, Russia and Zambia. RESULTS: Of the strategies considered, acute treatment of attacks with acetylsalicylic acid (ASA) was by far the most cost-effective and generated a HLY for less than US$ 100. Adding educational actions increased annual costs by 1-2 US cents per capita of the population. Cost-effectiveness ratios then became slightly less favourable but still less than US$ 100 per HLY gained for ASA. An incremental cost of > US$ 10,000 would have to be paid per extra HLY by adding a triptan in a stepped-care treatment paradigm. For prophylaxis, amitriptyline was more cost-effective than propranolol or topiramate. CONCLUSIONS: Self-management with simple analgesics was by far the most cost-effective strategy for migraine treatment in low- and middle-income countries and represents a highly efficient use of health resources. Consumer education and provider training are expected to accelerate progress towards desired levels of coverage and adherence, cost relatively little to implement, and can therefore be considered also economically attractive. Evidence-based interventions for migraine should have as much a claim on scarce health resources as those for other chronic, non-communicable conditions that impose a significant burden on societies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The global burden of headache: A documentation of headache prevalence and disability worldwide
Stovner, L., Hagen, K., Jensen, R., Katsarava, Z., Lipton, R., Scher, A., Steiner, T., & Zwart, J.-A. (2007) · Cephalalgia · doi:10.1111/j.1468-2982.2007.01288.x · Cited by 2,444
Self-citationOlesen, J. (2004) · Cephalalgia · doi:10.1111/j.1468-2982.2003.00824.x · Cited by 2,056
EFNS guideline on the drug treatment of migraine—revised report of an EFNS task force
Evers, S., Áfra, J., Frese, A., Goadsby, P. J., Linde, M., May, A., & Sándor, P. S. (2009) · European Journal of Neurology · doi:10.1111/j.1468-1331.2009.02748.x · Cited by 892
Self-citationMigraine: the seventh disabler
Steiner, T. J., Stovner, L. J., & Birbeck, G. L. (2013) · The Journal of Headache and Pain · doi:10.1186/1129-2377-14-1 · Cited by 335 · cited 1×
“The context in which this finding must be set is that migraine is the third most prevalent disease in the world, and the seventh highest specific cause of global disability [2,43].”
BackgroundSelf-citationThe prevalence of primary headache disorders in Russia: A countrywide survey
Ayzenberg, I., Katsarava, Z., Sborowski, A., Chernysh, M., Osipova, V, Tabeeva, G., Yakhno, N., Steiner, T., & Burden, O. B. O. L. T. (2012) · Cephalalgia · doi:10.1177/0333102412438977 · Cited by 227
Self-citation
Cited by
Stovner, L. J., Nichols, E., Steiner, T. J., Abd-Allah, F., Abdelalim, A., Al-Raddadi, R. M., Ansha, M. G., Barac, A., Bensenor, I. M., Doan, L. P., et al. (2018) · The Lancet Neurology · doi:10.1016/s1474-4422(18)30322-3 · Cited by 1,908
Self-citationHeadache, O. B. O. L. T. B. T. G. C. A., Steiner, T. J., Stovner, L. J., Jensen, R., Uluduz, D., & Katsarava, Z. (2020) · The Journal of Headache and Pain · doi:10.1186/s10194-020-01208-0 · Cited by 1,035
Self-citationMigraine: epidemiology and systems of care
Ashina, M., Katsarava, Z., Do, T. P., Buse, D. C., Pozo-Rosich, P., Özge, A., Krymchantowski, A. V., Lebedeva, E. R., Ravishankar, K., Yu, S., et al. (2021) · The Lancet · doi:10.1016/s0140-6736(20)32160-7 · Cited by 833
Self-citationMigraine is first cause of disability in under 50s: will health politicians now take notice?
Steiner, T. J., Stovner, L. J., Vos, T., Jensen, R., & Katsarava, Z. (2018) · The Journal of Headache and Pain · doi:10.1186/s10194-018-0846-2 · Cited by 642
Self-citationSteiner, T., & Saylor, D. (2018) · Seminars in Neurology · doi:10.1055/s-0038-1646946 · Cited by 324
Self-citation
Metadata
- Authors
- Linde, M., Steiner, T. J., & Chisholm, D.
- Venue
- The Journal of Headache and Pain
- Published
- 2015-02-18
- Volume
- 16
- Issue
- 1
- Pages
- 15-15
- ISSN
- 1129-2369 (ISSN-L)
- 1129-2377
- OpenAlex
- W2147900940
- Cited by
- 53
- References
- 5
- FWCI
- 4.34
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Cost-effectiveness analysis of interventions for migraine in four low- and middle-income countries. https://app.cochat.ai/papers/10.1186/s10194-015-0496-6
- The paper
- Linde, M., Steiner, T. J., & Chisholm, D. (2015). Cost-effectiveness analysis of interventions for migraine in four low- and middle-income countries. The Journal of Headache and Pain. https://doi.org/10.1186/s10194-015-0496-6
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.